RNAi therapeutics: SNALPing siRNAs in vivo

Gene Therapy

Volumn 13, Issue 7, 2006, Pages 583-584

  Rossi, J J ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DOUBLE STRANDED RNA; IMMUNOGLOBULIN F(AB')2 FRAGMENT; INTERFERON; MACROGOL; NUCLEASE; PROTAMINE; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7;

DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG HALF LIFE; GENE SEQUENCE; HEPATITIS B; HEPATITIS B VIRUS; HYPERCHOLESTEROLEMIA; IN VIVO STUDY; INNATE IMMUNITY; JEJUNUM; LIVER; LIVER CELL; LIVER DISEASE; MACROMOLECULE; MAMMAL CELL; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; NOTE; PRIORITY JOURNAL; RNA INTERFERENCE; VIRUS INHIBITION; VIRUS REPLICATION;

ANIMALS; DRUG DELIVERY SYSTEMS; GENE THERAPY; HEPATITIS B VIRUS; MICE; RNA INTERFERENCE; RNA, SMALL INTERFERING;

HEPATITIS B VIRUS; MAMMALIA;

EID: 33645108129     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/sj.gt.3302661     Document Type: Note

References (10)

1. Caplen NJ, Parrish S, Imani F, Fire A, Morgan RA. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci USA 2001; 98: 9742-9747.
2. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494-498.
3. Morrissey DV, Blanchard K, Shaw L, Jensen K, Lockridge JA, Dickinson B et al. Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication. Hepatology 2005; 41: 1349-1356.
4. Morrissey DV, Lockridge JA, Shaw L, Blanchard K, Jensen K, Breen W et al. Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol 2005; 23: 1002-1007.
5. Song E, Zhu P, Lee SK, Chowdhury D, Kussman S, Dykxhoorn DM et al. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat Biotechnol 2005; 23: 709-717.
6. Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, Donoghue M et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 2004; 432: 173-178.
7. Sioud M. Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. J Mol Biol 2005; 348: 1079-1090.
8. Ma Z, Li J, He F, Wilson A, Pitt B, Li S. Cationic lipids enhance siRNA-mediated interferon response in mice. Biochem Biophys Res Commun 2005; 330: 755-759.
9. Judge AD, Sood V, Shaw JR, Fang D, McClintock K, MacLachlan I. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat Biotechnol 2005; 23: 457-462.
10. Hornung V, Guenthner-Biller M, Bourquin C, Ablasser A, Schlee M, Uematsu S et al. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med 2005; 11: 263-270.